Evaluación y tratamiento de la enfermedad intersticial pulmonar en la Argentina / Evaluation and treatment of interstitial lung disease in Argentine
Mosca, Carlos; Quadrelli, Silvia; Castro Zorrilla, Liliana; Castagnino, Jorge.
Medicina [B.Aires]
; 60(6): 907-913, Dic. 2000.
Artículo
en Español
| BINACIS | ID: bin-7407
To determine the availability and usual management of interstitial lung diseases (ILD) in our country, the Section of Interstitial Lung Diseases of the Argentine Association for Respiratory Medicine (AAMR) made a survey about diagnostic methodology and treatment of ILD. A total of 115 answers were obtained (38.5), 43 of them among physicians living in the provinces. Availability of diffusing capacity of the lung for carbon monoxide test (DLCO) is limited 25.4 never have access to it and 35.6 can seldom use it. Availability to thoracic CT scan is wider 85 may use if often (32.4) or always (52.6). Bronchoscopy is commonly available in 87.7 of the physicians either often (21.9) or always (65.8). However, only 20.2 perform BAL and 13.1 transbronchial biopsy in every patient. Only 16.6 perform open lung biopsy or thoracoscopic biopsy in all or most of their patients. Sixty eight percent of physicians who always have availability of DLCO perform it in every patient but only 7.1 of those who seldom have access to DLCO do so (p = 0.0003). Availability of bronchoscopy does not have any influence on the decision of performing BAL or transbronchial biopsy. Frequency of use of surgical biopsy or treatment with immunosuppressive drugs was not influenced by any variable. We conclude that there is a current trend to underuse diagnostic resources for ILD in Argentina. Limitations in availability are relevant regarding DLCO. An effort from the health authorities to centralize the management of patients with ILD would allow to study and treat them according to international recommendations.(Au)
Biblioteca responsable:
BR1.1
Documentos relacionados